Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells
- 30 April 1993
- Vol. 14 (2) , 241-246
- https://doi.org/10.1016/0196-9781(93)90036-g
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytesBrain Research, 1991
- Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: characterization and molecular identification 1The FASEB Journal, 1991
- Vasoactive intestinal polypeptide binds with high affinity to non-small cell lung cancer cells and elevates cyclic AMP levelsPeptides, 1990
- Binding sites of a novel neuropeptide pituitary‐adenylate‐cyclase‐activating polypeptide in the rat brain and lungEuropean Journal of Biochemistry, 1990
- Characterization and Distribution of Binding Sites for the Hypothalamic Peptide, Pituitary Adenylate Cyclase-Activating Polypeptide*Endocrinology, 1990
- Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38)Biochemical and Biophysical Research Communications, 1990
- The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OKPeptides, 1990
- Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cellsBiochemical and Biophysical Research Communications, 1989
- Somatostatin inhibits the secretion of bombesin-like peptides from small cell lung cancer cellsPeptides, 1988
- Mechanism of C-terminal amide formation by pituitary enzymesNature, 1982